| |
| |
|
| Insider
Information: |
Grey Michael G |
| Relationship: |
Executive Chairman, Di... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
48,571 |
|
|
Indirect Shares
|
1,011,794 |
|
|
| Direct
Value |
$4,133,319 |
|
|
|
Indirect Value
|
$1,043,884 |
|
|
| Total
Shares |
1,060,365 |
|
|
| Total
Value |
$5,177,203 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sgx Pharmaceuticals, Inc. |
SGXP |
President & CEO, Direc... |
|
0 |
2008-08-20 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2021-03-05 |
42,840 |
2008-03-05 |
0 |
Premium* |
|
|
Horizon Pharma, Inc. |
HZNP |
Director |
2023-10-06 |
0 |
2023-10-06 |
0 |
Premium* |
|
|
Mirati Therapeutics, Inc. |
MRTX |
|
2021-01-15 |
5,731 |
2019-05-13 |
0 |
Premium* |
|
|
Mirum Pharmaceuticals, Inc. |
MIRM |
Director |
2023-09-14 |
0 |
2023-09-14 |
382,948 |
Premium* |
|
|
Reneo Pharmaceuticals, Inc. |
RPHM |
Executive Chairman, Di... |
2023-07-26 |
0 |
2023-07-26 |
628,846 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
86 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2020-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
4,256 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2020-12-14 |
4 |
OE |
$16.84 |
$183,556 |
D/D |
10,900 |
15,156 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2020-12-14 |
4 |
AS |
$241.22 |
$2,675,345 |
D/D |
(10,900) |
4,256 |
0 |
% |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,475 |
5,731 |
0 |
- |
|
| RPHM |
Reneo Pharmaceuticals, In... |
Executive ChairmanOfficer |
• • – |
2021-04-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
558,685 |
|
- |
|
| RPHM |
Reneo Pharmaceuticals, In... |
Executive ChairmanOfficer |
• • – |
2021-04-08 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
424,600 |
|
- |
|
| RPHM |
Reneo Pharmaceuticals, In... |
Executive Chairman |
• • – |
2021-04-13 |
4 |
A |
$0.00 |
$0 |
I/I |
20,162 |
444,762 |
0 |
- |
|
| RPHM |
Reneo Pharmaceuticals, In... |
Executive Chairman |
• • – |
2022-08-31 |
4 |
OE |
$1.97 |
$98,500 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| RPHM |
Reneo Pharmaceuticals, In... |
Executive Chairman |
• • – |
2023-07-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
50,000 |
0 |
0 |
- |
|
| SGXP |
Sgx Pharmaceuticals, Inc. |
officerTitle |
• • – |
2006-01-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
100,000 |
|
- |
|
| SGXP |
Sgx Pharmaceuticals, Inc. |
President & CEO |
• • – |
2008-08-20 |
4 |
D |
$3.00 |
$300,000 |
I/I |
(100,000) |
0 |
0 |
- |
|
86 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
